RBC Capital Maintains Outperform on Verastem, Raises Price Target to $19

RBC Capital analyst Leonid Timashev has maintained an 'Outperform' rating on Verastem (NASDAQ: VSTM) and raised the price target from $14 to $19. This adjustment reflects a positive outlook on the company's performance.